|Study Description:||This is a 2 part study. The goal of the first part of this clinical research |
study is to find the highest tolerable dose of azacitidine that can be given
with a TKI that you are already taking (such as Gleevec, Sprycel, or Tasigna).
The safety of this drug will also be studied. The goal of the second part is to
see if this combination may improve your response to the TKI you are already
Azacitidine is designed to change genes that are thought to cause leukemia. By
changing these genes, the drug may help to stop them from causing the disease